Systemic Inflammation Response Index is an Independent Prognostic Indicator for Patients with Renal Cell Carcinoma Undergoing Laparoscopic Nephrectomy: A Multi-Institutional Cohort Study

Weipu Mao,1– 3,* Si Sun,1,* Ting He,1,* Xin Jin,4,* Jianping Wu,1 Bin Xu,1 Guangyuan Zhang,1 Keyi Wang,5,* Ming Chen1– 3 1Department of Urology, Affiliated Zhongda Hospital of Southeast University, Nanjing, 210009, People’s Republic of China; 2Surgical Researc...

Full description

Bibliographic Details
Main Authors: Mao W, Sun S, He T, Jin X, Wu J, Xu B, Zhang G, Wang K, Chen M
Format: Article
Language:English
Published: Dove Medical Press 2021-08-01
Series:Cancer Management and Research
Subjects:
Online Access:https://www.dovepress.com/systemic-inflammation-response-index-is-an-independent-prognostic-indi-peer-reviewed-fulltext-article-CMAR
id doaj-6e19eafc28ca48c4ac62703962db825f
record_format Article
spelling doaj-6e19eafc28ca48c4ac62703962db825f2021-08-22T20:34:13ZengDove Medical PressCancer Management and Research1179-13222021-08-01Volume 136437645067920Systemic Inflammation Response Index is an Independent Prognostic Indicator for Patients with Renal Cell Carcinoma Undergoing Laparoscopic Nephrectomy: A Multi-Institutional Cohort StudyMao WSun SHe TJin XWu JXu BZhang GWang KChen MWeipu Mao,1– 3,&ast; Si Sun,1,&ast; Ting He,1,&ast; Xin Jin,4,&ast; Jianping Wu,1 Bin Xu,1 Guangyuan Zhang,1 Keyi Wang,5,&ast; Ming Chen1– 3 1Department of Urology, Affiliated Zhongda Hospital of Southeast University, Nanjing, 210009, People’s Republic of China; 2Surgical Research Center, Institute of Urology, Southeast University Medical School, Nanjing, 210009, People’s Republic of China; 3Department of Urology, Nanjing Lishui District People’s Hospital, Zhongda Hospital Lishui Branch, Southeast University, Nanjing, 211200, People’s Republic of China; 4Department of Urology, Taizhou People’s Hospital, Taizhou, 225700, People’s Republic of China; 5Department of Urology, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University, Shanghai, 200072, People’s Republic of China&ast;These authors contributed equally to this workCorrespondence: Ming Chen; Guangyuan ZhangDepartment of Urology, Affiliated Zhongda Hospital of Southeast University, No. 87 Dingjiaqiao, Hunan Road, Gulou District, Nanjing, 210009, People’s Republic of ChinaTel +86-13913009977; +86-13951658634Fax +86-13913009977; +86-13770334095Email mingchenseu@126.com; zgy0879@qq.comBackground: We conducted a multicenter clinical study to examine the prognostic value of the systemic inflammation response index (SIRI) in renal cell carcinoma (RCC) patients.Methods: We collected patients who underwent nephrectomy from 2014 to 2019 at three centers (343 in the training group and 100 in the validation group). SIRI was created based on hemoglobin and lymphocyte to monocyte ratio (LMR). Kaplan–Meier curves and receiver operating characteristic (ROC) curves were used to analyze the effect of LMR, hemoglobin and SIRI on overall survival (OS) and cancer-specific survival (CSS) effects.Results: In both the training and validation groups, SIRI was a better predictor of OS and CSS than LMR and hemoglobin. A total of 192 (56.0%) patients were included in grade 1, 108 (31.5%) in grade 2, and 43 (12.5%) in grade 3 based on SIRI in the training group. Higher SIRI was associated with worse prognosis. Multivariate cox regression analysis showed that SIRI was an independent prognostic risk factor for OS (grade 3 vs grade 1: HR=4.93; 95% CI 2.21– 11.00, p < 0.001) and CSS (grade 3 vs grade 1: HR=6.29; 95% CI 2.28– 17.39, p < 0.001) in patients with RCC. In addition, SIRI-based prognostic nomograms were able to better predict OS and CSS in RCC patients.Conclusion: SIRI is an independent prognostic factor for patients undergoing laparoscopic nephrectomy for RCC, and a prognostic nomogram covering SIRI can better predict survival of RCC patients.Keywords: renal cell carcinoma, systemic inflammation response index, nomogram, prognostic indicatorhttps://www.dovepress.com/systemic-inflammation-response-index-is-an-independent-prognostic-indi-peer-reviewed-fulltext-article-CMARrenal cell carcinomasystemic inflammation response indexnomogramprognostic indicator
collection DOAJ
language English
format Article
sources DOAJ
author Mao W
Sun S
He T
Jin X
Wu J
Xu B
Zhang G
Wang K
Chen M
spellingShingle Mao W
Sun S
He T
Jin X
Wu J
Xu B
Zhang G
Wang K
Chen M
Systemic Inflammation Response Index is an Independent Prognostic Indicator for Patients with Renal Cell Carcinoma Undergoing Laparoscopic Nephrectomy: A Multi-Institutional Cohort Study
Cancer Management and Research
renal cell carcinoma
systemic inflammation response index
nomogram
prognostic indicator
author_facet Mao W
Sun S
He T
Jin X
Wu J
Xu B
Zhang G
Wang K
Chen M
author_sort Mao W
title Systemic Inflammation Response Index is an Independent Prognostic Indicator for Patients with Renal Cell Carcinoma Undergoing Laparoscopic Nephrectomy: A Multi-Institutional Cohort Study
title_short Systemic Inflammation Response Index is an Independent Prognostic Indicator for Patients with Renal Cell Carcinoma Undergoing Laparoscopic Nephrectomy: A Multi-Institutional Cohort Study
title_full Systemic Inflammation Response Index is an Independent Prognostic Indicator for Patients with Renal Cell Carcinoma Undergoing Laparoscopic Nephrectomy: A Multi-Institutional Cohort Study
title_fullStr Systemic Inflammation Response Index is an Independent Prognostic Indicator for Patients with Renal Cell Carcinoma Undergoing Laparoscopic Nephrectomy: A Multi-Institutional Cohort Study
title_full_unstemmed Systemic Inflammation Response Index is an Independent Prognostic Indicator for Patients with Renal Cell Carcinoma Undergoing Laparoscopic Nephrectomy: A Multi-Institutional Cohort Study
title_sort systemic inflammation response index is an independent prognostic indicator for patients with renal cell carcinoma undergoing laparoscopic nephrectomy: a multi-institutional cohort study
publisher Dove Medical Press
series Cancer Management and Research
issn 1179-1322
publishDate 2021-08-01
description Weipu Mao,1– 3,&ast; Si Sun,1,&ast; Ting He,1,&ast; Xin Jin,4,&ast; Jianping Wu,1 Bin Xu,1 Guangyuan Zhang,1 Keyi Wang,5,&ast; Ming Chen1– 3 1Department of Urology, Affiliated Zhongda Hospital of Southeast University, Nanjing, 210009, People’s Republic of China; 2Surgical Research Center, Institute of Urology, Southeast University Medical School, Nanjing, 210009, People’s Republic of China; 3Department of Urology, Nanjing Lishui District People’s Hospital, Zhongda Hospital Lishui Branch, Southeast University, Nanjing, 211200, People’s Republic of China; 4Department of Urology, Taizhou People’s Hospital, Taizhou, 225700, People’s Republic of China; 5Department of Urology, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University, Shanghai, 200072, People’s Republic of China&ast;These authors contributed equally to this workCorrespondence: Ming Chen; Guangyuan ZhangDepartment of Urology, Affiliated Zhongda Hospital of Southeast University, No. 87 Dingjiaqiao, Hunan Road, Gulou District, Nanjing, 210009, People’s Republic of ChinaTel +86-13913009977; +86-13951658634Fax +86-13913009977; +86-13770334095Email mingchenseu@126.com; zgy0879@qq.comBackground: We conducted a multicenter clinical study to examine the prognostic value of the systemic inflammation response index (SIRI) in renal cell carcinoma (RCC) patients.Methods: We collected patients who underwent nephrectomy from 2014 to 2019 at three centers (343 in the training group and 100 in the validation group). SIRI was created based on hemoglobin and lymphocyte to monocyte ratio (LMR). Kaplan–Meier curves and receiver operating characteristic (ROC) curves were used to analyze the effect of LMR, hemoglobin and SIRI on overall survival (OS) and cancer-specific survival (CSS) effects.Results: In both the training and validation groups, SIRI was a better predictor of OS and CSS than LMR and hemoglobin. A total of 192 (56.0%) patients were included in grade 1, 108 (31.5%) in grade 2, and 43 (12.5%) in grade 3 based on SIRI in the training group. Higher SIRI was associated with worse prognosis. Multivariate cox regression analysis showed that SIRI was an independent prognostic risk factor for OS (grade 3 vs grade 1: HR=4.93; 95% CI 2.21– 11.00, p < 0.001) and CSS (grade 3 vs grade 1: HR=6.29; 95% CI 2.28– 17.39, p < 0.001) in patients with RCC. In addition, SIRI-based prognostic nomograms were able to better predict OS and CSS in RCC patients.Conclusion: SIRI is an independent prognostic factor for patients undergoing laparoscopic nephrectomy for RCC, and a prognostic nomogram covering SIRI can better predict survival of RCC patients.Keywords: renal cell carcinoma, systemic inflammation response index, nomogram, prognostic indicator
topic renal cell carcinoma
systemic inflammation response index
nomogram
prognostic indicator
url https://www.dovepress.com/systemic-inflammation-response-index-is-an-independent-prognostic-indi-peer-reviewed-fulltext-article-CMAR
work_keys_str_mv AT maow systemicinflammationresponseindexisanindependentprognosticindicatorforpatientswithrenalcellcarcinomaundergoinglaparoscopicnephrectomyamultiinstitutionalcohortstudy
AT suns systemicinflammationresponseindexisanindependentprognosticindicatorforpatientswithrenalcellcarcinomaundergoinglaparoscopicnephrectomyamultiinstitutionalcohortstudy
AT het systemicinflammationresponseindexisanindependentprognosticindicatorforpatientswithrenalcellcarcinomaundergoinglaparoscopicnephrectomyamultiinstitutionalcohortstudy
AT jinx systemicinflammationresponseindexisanindependentprognosticindicatorforpatientswithrenalcellcarcinomaundergoinglaparoscopicnephrectomyamultiinstitutionalcohortstudy
AT wuj systemicinflammationresponseindexisanindependentprognosticindicatorforpatientswithrenalcellcarcinomaundergoinglaparoscopicnephrectomyamultiinstitutionalcohortstudy
AT xub systemicinflammationresponseindexisanindependentprognosticindicatorforpatientswithrenalcellcarcinomaundergoinglaparoscopicnephrectomyamultiinstitutionalcohortstudy
AT zhangg systemicinflammationresponseindexisanindependentprognosticindicatorforpatientswithrenalcellcarcinomaundergoinglaparoscopicnephrectomyamultiinstitutionalcohortstudy
AT wangk systemicinflammationresponseindexisanindependentprognosticindicatorforpatientswithrenalcellcarcinomaundergoinglaparoscopicnephrectomyamultiinstitutionalcohortstudy
AT chenm systemicinflammationresponseindexisanindependentprognosticindicatorforpatientswithrenalcellcarcinomaundergoinglaparoscopicnephrectomyamultiinstitutionalcohortstudy
_version_ 1721199227364704256